Genomic outbreak intelligence is what hospital clients will expect. Theiagen helps you offer it first.
Hospital systems are beginning to expect genomic clarity from their reference lab partners. Theiagen builds the capability that lets you deliver it — before your competitors do.
We understand your world
Most commercial and reference labs’ genomic support are focused on clinical lines, like oncology, neurology, etc. To address pathogen outbreak intelligence, you need a different discipline entirely — and right now, no reference lab is offering it at scale.
The reference labs that build this capability first will differentiate their offering, deepen their hospital relationships, and open new reimbursement and contract opportunities. The ones that wait will find themselves being asked the question by clients they can't answer.
The opportunity
- Genomic surveillance and outbreak intelligence will be the next standard in hospitals — the direction is clear
- Large hospital systems need outbreak clarity and currently have no good commercial source for it
- Commercial lab reporting on genomic data is often unclear — the bar to differentiate is low
- Being first creates competitive advantage, stronger hospital relationships, and new revenue potential
Your challenges
- Adding genomic outbreak intelligence without disrupting existing clinical genomics workflows or infrastructure
- Building the bioinformatics and interpretation capability you don't currently have in-house
- Translating genomic data into clear, actionable reports your hospital clients can actually use
- Justifying the investment ahead of explicit client demand
How Theiagen helps
We build the genomic workflow and bioinformatics interpretation layer that lets your lab answer the questions your hospital clients are already asking — which specimens are linked, which aren't, and what that means clinically.
Your lab brings the relationship and the infrastructure. Theiagen brings the science, systems, and strategy to operationalize pathogen genomics. Together you deliver genomic outbreak intelligence your hospital clients can't easily get anywhere else.
Whether we run it for you or build it alongside your internal team — your lab becomes the partner hospitals turn to for outbreak intelligence.
Theiagen builds steps 3 and 4. Your lab delivers steps 1, 2, and 5. Your hospital clients get the outbreak answer they need — from a partner they already trust.
Why trust Theiagen
Theiagen brings the full breadth of pathogen expertise — microbiology, bioinformatics, epidemiology, and software systems — to organizations that need reliable, proven genomic intelligence at scale. Our track record across 40+ public health labs demonstrates the scientific depth, operational reliability, and breadth of pathogen coverage our clients depend on.
Frequently Asked Questions
Why should commercial reference laboratories invest in pathogen genomics?
Healthcare organizations increasingly expect more precise infectious disease intelligence from their laboratory partners. Pathogen genomics creates opportunities to differentiate services, strengthen customer relationships, support higher-value reporting, and develop new sources of revenue in infectious disease diagnostics and outbreak intelligence.
How can pathogen genomics create new revenue opportunities for commercial laboratories?
Pathogen genomics enables laboratories to develop new infectious disease intelligence services, expand relationships with existing healthcare customers, and provide higher-value insights that extend beyond traditional testing. These capabilities can create opportunities for differentiated contracts, specialized services, and new growth avenues.
Why are hospitals beginning to expect genomic outbreak intelligence from their reference laboratory partners?
Hospitals increasingly seek more precise information about transmission pathways, outbreak linkage, and antimicrobial resistance than traditional laboratory reporting can provide. As pathogen genomics becomes more widely adopted, healthcare organizations are beginning to expect these advanced insights from their laboratory partners.
What genomic outbreak intelligence do hospital clients need from reference laboratories?
Hospitals need to know whether cases are linked, how transmission occurred, and whether antimicrobial resistance patterns suggest a common source. They need clear, actionable information that infection prevention teams can use to guide interventions, improve patient safety, and support operational decision-making.
How does Theiagen help commercial reference laboratories offer genomic services to hospitals?
Theiagen builds the genomic workflow and interpretation layer between a laboratory’s existing sequencing infrastructure and the outbreak intelligence hospitals increasingly need. We provide the bioinformatics, scientific expertise, and reporting capabilities necessary to deliver actionable pathogen insights without disrupting your core laboratory operations.
Can commercial laboratories add pathogen genomics without replacing existing infrastructure?
Yes. Pathogen genomics capabilities can be integrated into existing sequencing, reporting, and laboratory workflows without requiring organizations to rebuild their core infrastructure. Theiagen works within your current environment to accelerate implementation and reduce operational disruption.
Does a commercial laboratory need in-house bioinformatics expertise to offer pathogen genomics services?
No. Many laboratories possess sequencing capabilities but lack specialized pathogen bioinformatics expertise. Theiagen can provide the scientific expertise, workflow development, interpretation, and training necessary to operationalize pathogen genomics as either a fully outsourced capability or one developed alongside your internal team.
How can pathogen genomics differentiate a commercial laboratory?
Pathogen genomics enables laboratories to provide advanced infectious disease intelligence that few organizations currently offer in a standardized way. These capabilities help laboratories strengthen customer relationships, position themselves as innovation leaders, and create meaningful differentiation in an increasingly competitive market.
How can commercial laboratories evaluate the return on investment of pathogen genomics?
The return on investment can come from differentiated services, expanded customer relationships, higher-value reporting, new contract opportunities, and increased retention of strategic healthcare accounts. Organizations should evaluate both direct revenue opportunities and the long-term competitive advantages of offering advanced infectious disease intelligence.
How does Theiagen compare to other bioinformatics consulting companies for pathogen genomics?
Unlike generalist bioinformatics consulting firms, Theiagen specializes exclusively in pathogen genomics. This means commercial labs work with scientists who understand the biology, the clinical context, and the operational demands of outbreak intelligence — not just the computational workflow.